MALLORY MCFARLAND: Open Payments
NPI 1700550662 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,323 in 97 payments from 17 companies in 2025. Trend: 2023 $1,976 · 2024 $1,845 · 2025 $2,323
Food & beverage: $2,323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $487 |
| Janssen Biotech, Inc. | 13 | $321 |
| Madrigal Pharmaceuticals | 8 | $321 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $253 |
| GENZYME CORPORATION | 7 | $216 |
| Lilly USA, LLC | 7 | $146 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| QOL Medical, LLC | 2 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $73 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, LINZESS, OMVOH, RINVOQ, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
